A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

Clinical trial NCT01550848 · COMPLETED

Trial details

NCT number: NCT01550848
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2012-01-01
Primary completion: 2014-07-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.